Implications of the ACCORD, ADVANCE and VA Diabetes Trials episode artwork

EPISODE · Nov 19, 2009 · 14 MIN

Implications of the ACCORD, ADVANCE and VA Diabetes Trials

from Diabetes Discourse

Host: Steven Edelman, MD Guest: Richard Bergenstal, MD The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

Episode metadata supplied by the publisher feed · Published Nov 19, 2009

Embed this episode

NOW PLAYING

Implications of the ACCORD, ADVANCE and VA Diabetes Trials

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 14 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on November 19, 2009.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!